- Live market news
- Stocks
- JNJ
Johnson & Johnson
JNJStockF
Johnson & Johnson
Kimmarie Johnson (born Kim Marie Johnson; April 8, 1976 – November 4, 2026) was an American actress, model, businesswoman and beauty pageant titleholder. She was the founder of SkinGlow by Kimmarie, a skin care and beauty retailing and consulting company she founded in 2011.
Earlier in her career, Johnson participated in and won the Miss Pennsylvania USA beauty pageant. She went on to represent the state of Pennsylvania in the Miss USA pageant.
Latest news on JNJranked by Oyticker for market impact
- 55Impact
J&J reports 2-year ICOTYDE durability data in plaque psoriasis, supporting first-line positioning
Johnson & Johnson announced positive two-year Phase 3 ICONIC-TOTAL study results for ICOTYDE (icotrokinra) in difficult-to-treat plaque psoriasis, demonstrating sustained efficacy and supporting its use as a first-line systemic therapy.
JNJPharmaceuticalsDermatology - 45Impact
J&J presents sustained efficacy data for IMAAVY in generalized myasthenia gravis
Johnson & Johnson disclosed new clinical findings on IMAAVY (nipocalimab-aahu) demonstrating sustained disease control and functional improvement in generalized myasthenia gravis patients. The data reinforces the drug's therapeutic profile in this rare autoimmune neuromuscular disorder.
JNJPharmaceuticalsBiotechnology - 62Impact
JNJ TREMFYA meets primary endpoints in axial PsA spinal pain study
Johnson & Johnson announced TREMFYA (guselkumab) met primary and major secondary endpoints in a landmark axial psoriatic arthritis trial, demonstrating efficacy in spinal pain and stiffness—a differentiated claim within the IL-23 inhibitor class.
JNJPharmaceuticalsImmunology
What JNJ filed
- 21 Oct 2026
- 13 Oct 2026
- 4 Aug 2026
- 29 Jul 2026
- 27 Jul 2026
- 23 Jul 2026
- 15 Jul 2026
From SEC EDGAR, the public record of what US-listed companies file. Each document opens on sec.gov.
Oyticker provides market information and analysis for educational purposes. It is not investment advice: you remain responsible for your own decisions.